GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Dmc1
|
ENSMUSG00000022429.10 | DNA meiotic recombinase 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Dmc1 | mm10_v2_chr15_-_79605084_79605114 | -0.52 | 1.1e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr13_+_4436094 | 7.22 |
ENSMUST00000156277.1
|
Akr1c6
|
aldo-keto reductase family 1, member C6 |
chr5_-_87337165 | 6.45 |
ENSMUST00000031195.2
|
Ugt2a3
|
UDP glucuronosyltransferase 2 family, polypeptide A3 |
chr19_+_40089688 | 5.09 |
ENSMUST00000068094.6
ENSMUST00000080171.2 |
Cyp2c50
|
cytochrome P450, family 2, subfamily c, polypeptide 50 |
chr4_-_107307118 | 4.80 |
ENSMUST00000126291.1
ENSMUST00000106748.1 ENSMUST00000129138.1 ENSMUST00000082426.3 |
Dio1
|
deiodinase, iodothyronine, type I |
chr3_+_142594847 | 4.51 |
ENSMUST00000029936.4
|
Gbp2b
|
guanylate binding protein 2b |
chr17_-_32917048 | 3.78 |
ENSMUST00000054174.7
|
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr13_-_23914998 | 3.71 |
ENSMUST00000021769.8
ENSMUST00000110407.2 |
Slc17a4
|
solute carrier family 17 (sodium phosphate), member 4 |
chr19_+_39007019 | 3.67 |
ENSMUST00000025966.4
|
Cyp2c55
|
cytochrome P450, family 2, subfamily c, polypeptide 55 |
chr13_-_56548534 | 3.58 |
ENSMUST00000062806.4
|
Lect2
|
leukocyte cell-derived chemotaxin 2 |
chr4_-_96664112 | 3.52 |
ENSMUST00000030299.7
|
Cyp2j5
|
cytochrome P450, family 2, subfamily j, polypeptide 5 |
chr5_-_86926521 | 3.41 |
ENSMUST00000031183.2
|
Ugt2b1
|
UDP glucuronosyltransferase 2 family, polypeptide B1 |
chr8_-_4105764 | 3.32 |
ENSMUST00000138439.1
ENSMUST00000145007.1 |
Cd209f
|
CD209f antigen |
chr19_-_40073731 | 3.20 |
ENSMUST00000048959.3
|
Cyp2c54
|
cytochrome P450, family 2, subfamily c, polypeptide 54 |
chr19_-_8405060 | 3.16 |
ENSMUST00000064507.5
ENSMUST00000120540.1 ENSMUST00000096269.4 |
Slc22a30
|
solute carrier family 22, member 30 |
chr7_-_12998172 | 3.02 |
ENSMUST00000120903.1
|
Slc27a5
|
solute carrier family 27 (fatty acid transporter), member 5 |
chr6_-_85933379 | 2.98 |
ENSMUST00000162660.1
|
Nat8b
|
N-acetyltransferase 8B |
chr7_-_12998140 | 2.92 |
ENSMUST00000032539.7
|
Slc27a5
|
solute carrier family 27 (fatty acid transporter), member 5 |
chr13_+_4434306 | 2.90 |
ENSMUST00000021630.8
|
Akr1c6
|
aldo-keto reductase family 1, member C6 |
chr19_-_46672883 | 2.84 |
ENSMUST00000026012.7
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1 |
chr17_-_74047850 | 2.81 |
ENSMUST00000043458.7
|
Srd5a2
|
steroid 5 alpha-reductase 2 |
chr8_+_104733997 | 2.69 |
ENSMUST00000034346.8
ENSMUST00000164182.2 |
Ces2a
|
carboxylesterase 2A |
chr10_+_87861309 | 2.53 |
ENSMUST00000122100.1
|
Igf1
|
insulin-like growth factor 1 |
chr14_+_69171576 | 2.43 |
ENSMUST00000062437.8
|
Nkx2-6
|
NK2 homeobox 6 |
chr1_+_58113136 | 2.42 |
ENSMUST00000040999.7
|
Aox3
|
aldehyde oxidase 3 |
chr14_+_30886476 | 2.41 |
ENSMUST00000006703.6
ENSMUST00000078490.5 ENSMUST00000120269.2 |
Itih4
|
inter alpha-trypsin inhibitor, heavy chain 4 |
chr19_+_39992424 | 2.38 |
ENSMUST00000049178.2
|
Cyp2c37
|
cytochrome P450, family 2. subfamily c, polypeptide 37 |
chr10_-_81291227 | 2.33 |
ENSMUST00000045744.6
|
Tjp3
|
tight junction protein 3 |
chr3_+_94377432 | 2.28 |
ENSMUST00000107292.1
|
Rorc
|
RAR-related orphan receptor gamma |
chr19_-_8218832 | 2.28 |
ENSMUST00000113298.2
|
Slc22a29
|
solute carrier family 22. member 29 |
chr3_+_94377505 | 2.25 |
ENSMUST00000098877.2
|
Rorc
|
RAR-related orphan receptor gamma |
chr1_-_193264006 | 2.24 |
ENSMUST00000161737.1
|
Hsd11b1
|
hydroxysteroid 11-beta dehydrogenase 1 |
chr18_-_56572888 | 2.21 |
ENSMUST00000174518.1
|
Aldh7a1
|
aldehyde dehydrogenase family 7, member A1 |
chr7_-_27337667 | 2.19 |
ENSMUST00000038618.6
ENSMUST00000108369.2 |
Ltbp4
|
latent transforming growth factor beta binding protein 4 |
chr1_+_74713551 | 2.16 |
ENSMUST00000027356.5
|
Cyp27a1
|
cytochrome P450, family 27, subfamily a, polypeptide 1 |
chr10_-_97726755 | 2.13 |
ENSMUST00000166373.1
|
C030005K15Rik
|
RIKEN cDNA C030005K15 gene |
chr7_-_119523477 | 2.13 |
ENSMUST00000033267.2
|
Pdilt
|
protein disulfide isomerase-like, testis expressed |
chr4_+_133553370 | 2.13 |
ENSMUST00000042706.2
|
Nr0b2
|
nuclear receptor subfamily 0, group B, member 2 |
chr3_-_107239707 | 2.11 |
ENSMUST00000049852.8
|
Prok1
|
prokineticin 1 |
chr17_-_31144271 | 2.10 |
ENSMUST00000024826.7
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr14_+_30886521 | 2.09 |
ENSMUST00000168782.1
|
Itih4
|
inter alpha-trypsin inhibitor, heavy chain 4 |
chr19_-_8131982 | 2.06 |
ENSMUST00000065651.4
|
Slc22a28
|
solute carrier family 22, member 28 |
chr7_-_100656953 | 2.04 |
ENSMUST00000107046.1
ENSMUST00000107045.1 ENSMUST00000139708.1 |
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr1_+_88166004 | 2.03 |
ENSMUST00000097659.4
|
Ugt1a5
|
UDP glucuronosyltransferase 1 family, polypeptide A5 |
chr15_+_33083110 | 2.02 |
ENSMUST00000042167.9
|
Cpq
|
carboxypeptidase Q |
chr11_+_48837465 | 1.97 |
ENSMUST00000046903.5
|
Trim7
|
tripartite motif-containing 7 |
chr9_+_111439063 | 1.93 |
ENSMUST00000111879.3
|
Dclk3
|
doublecortin-like kinase 3 |
chr9_+_92275602 | 1.85 |
ENSMUST00000034932.7
ENSMUST00000180154.1 |
Plscr2
|
phospholipid scramblase 2 |
chr19_-_39886730 | 1.76 |
ENSMUST00000168838.1
|
Cyp2c69
|
cytochrome P450, family 2, subfamily c, polypeptide 69 |
chr4_-_108071327 | 1.76 |
ENSMUST00000106701.1
|
Scp2
|
sterol carrier protein 2, liver |
chr3_+_137624031 | 1.65 |
ENSMUST00000165845.1
|
Ddit4l
|
DNA-damage-inducible transcript 4-like |
chr5_-_28055440 | 1.65 |
ENSMUST00000181503.1
|
Gm26608
|
predicted gene, 26608 |
chr4_-_41640322 | 1.64 |
ENSMUST00000127306.1
|
Enho
|
energy homeostasis associated |
chr13_-_22219820 | 1.59 |
ENSMUST00000057516.1
|
Vmn1r193
|
vomeronasal 1 receptor 193 |
chr10_-_95415283 | 1.55 |
ENSMUST00000119917.1
|
Socs2
|
suppressor of cytokine signaling 2 |
chr1_+_181051232 | 1.53 |
ENSMUST00000036819.6
|
9130409I23Rik
|
RIKEN cDNA 9130409I23 gene |
chr5_+_127632238 | 1.47 |
ENSMUST00000118139.1
|
Glt1d1
|
glycosyltransferase 1 domain containing 1 |
chr1_+_21240597 | 1.44 |
ENSMUST00000121676.1
|
Gsta3
|
glutathione S-transferase, alpha 3 |
chr11_+_108381164 | 1.43 |
ENSMUST00000146050.1
ENSMUST00000152958.1 |
Apoh
|
apolipoprotein H |
chr6_-_128526703 | 1.41 |
ENSMUST00000143664.1
ENSMUST00000112132.1 ENSMUST00000032510.7 |
Pzp
|
pregnancy zone protein |
chr1_+_131797381 | 1.41 |
ENSMUST00000112393.2
ENSMUST00000048660.5 |
Pm20d1
|
peptidase M20 domain containing 1 |
chr11_+_75468040 | 1.39 |
ENSMUST00000043598.7
ENSMUST00000108435.1 |
Tlcd2
|
TLC domain containing 2 |
chr4_+_134396320 | 1.39 |
ENSMUST00000105869.2
|
Pafah2
|
platelet-activating factor acetylhydrolase 2 |
chr6_-_130026954 | 1.39 |
ENSMUST00000074056.2
|
Klra6
|
killer cell lectin-like receptor, subfamily A, member 6 |
chr5_+_87000838 | 1.37 |
ENSMUST00000031186.7
|
Ugt2b35
|
UDP glucuronosyltransferase 2 family, polypeptide B35 |
chr18_-_61536522 | 1.32 |
ENSMUST00000171629.1
|
Arhgef37
|
Rho guanine nucleotide exchange factor (GEF) 37 |
chr13_+_23839401 | 1.31 |
ENSMUST00000039721.7
ENSMUST00000166467.1 |
Slc17a3
|
solute carrier family 17 (sodium phosphate), member 3 |
chr14_-_29721835 | 1.31 |
ENSMUST00000022567.7
|
Cacna2d3
|
calcium channel, voltage-dependent, alpha2/delta subunit 3 |
chr1_+_21240581 | 1.31 |
ENSMUST00000027067.8
|
Gsta3
|
glutathione S-transferase, alpha 3 |
chr9_+_37613806 | 1.29 |
ENSMUST00000002007.3
|
Siae
|
sialic acid acetylesterase |
chr8_-_70857008 | 1.29 |
ENSMUST00000110081.3
ENSMUST00000110078.3 |
Kcnn1
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1 |
chr1_+_88095054 | 1.28 |
ENSMUST00000150634.1
ENSMUST00000058237.7 |
Ugt1a7c
|
UDP glucuronosyltransferase 1 family, polypeptide A7C |
chr10_-_77113676 | 1.27 |
ENSMUST00000072755.4
ENSMUST00000105409.1 |
Col18a1
|
collagen, type XVIII, alpha 1 |
chrX_+_36598199 | 1.27 |
ENSMUST00000073339.6
|
Pgrmc1
|
progesterone receptor membrane component 1 |
chr3_+_81996922 | 1.27 |
ENSMUST00000029641.3
|
Asic5
|
acid-sensing (proton-gated) ion channel family member 5 |
chr9_-_121916288 | 1.25 |
ENSMUST00000062474.4
|
Cyp8b1
|
cytochrome P450, family 8, subfamily b, polypeptide 1 |
chr5_+_137569851 | 1.25 |
ENSMUST00000031729.8
|
Tfr2
|
transferrin receptor 2 |
chr4_+_95557494 | 1.24 |
ENSMUST00000079223.4
ENSMUST00000177394.1 |
Fggy
|
FGGY carbohydrate kinase domain containing |
chr10_-_77113928 | 1.21 |
ENSMUST00000149744.1
|
Col18a1
|
collagen, type XVIII, alpha 1 |
chr6_+_71199827 | 1.19 |
ENSMUST00000067492.7
|
Fabp1
|
fatty acid binding protein 1, liver |
chr5_-_86906937 | 1.17 |
ENSMUST00000031181.9
ENSMUST00000113333.1 |
Ugt2b34
|
UDP glucuronosyltransferase 2 family, polypeptide B34 |
chr10_-_128589650 | 1.17 |
ENSMUST00000082059.6
|
Erbb3
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) |
chr8_+_4134733 | 1.16 |
ENSMUST00000130372.1
|
Cd209g
|
CD209g antigen |
chr11_-_116199040 | 1.15 |
ENSMUST00000066587.5
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr17_+_12584183 | 1.14 |
ENSMUST00000046959.7
|
Slc22a2
|
solute carrier family 22 (organic cation transporter), member 2 |
chr9_+_92275746 | 1.14 |
ENSMUST00000126911.1
|
Plscr2
|
phospholipid scramblase 2 |
chr5_-_87569023 | 1.14 |
ENSMUST00000113314.2
|
Sult1d1
|
sulfotransferase family 1D, member 1 |
chr7_-_29248375 | 1.14 |
ENSMUST00000032808.4
|
2200002D01Rik
|
RIKEN cDNA 2200002D01 gene |
chr19_-_39812744 | 1.14 |
ENSMUST00000162507.1
ENSMUST00000160476.1 |
Cyp2c40
|
cytochrome P450, family 2, subfamily c, polypeptide 40 |
chr6_-_130386874 | 1.14 |
ENSMUST00000032288.4
|
Klra1
|
killer cell lectin-like receptor, subfamily A, member 1 |
chr4_+_43267165 | 1.13 |
ENSMUST00000107942.2
ENSMUST00000102953.3 |
Atp8b5
|
ATPase, class I, type 8B, member 5 |
chr4_+_43381979 | 1.12 |
ENSMUST00000035645.5
ENSMUST00000144911.1 |
Rusc2
|
RUN and SH3 domain containing 2 |
chr3_-_98753465 | 1.12 |
ENSMUST00000094050.4
ENSMUST00000090743.6 |
Hsd3b3
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3 |
chr5_-_104021919 | 1.11 |
ENSMUST00000031251.9
|
Hsd17b11
|
hydroxysteroid (17-beta) dehydrogenase 11 |
chr10_+_62071014 | 1.11 |
ENSMUST00000053865.5
|
Gm5424
|
predicted gene 5424 |
chr4_+_148602527 | 1.10 |
ENSMUST00000105701.2
ENSMUST00000052060.6 |
Masp2
|
mannan-binding lectin serine peptidase 2 |
chr9_-_9239019 | 1.09 |
ENSMUST00000183182.1
|
Arhgap42
|
Rho GTPase activating protein 42 |
chr3_-_63929376 | 1.09 |
ENSMUST00000061706.6
|
E130311K13Rik
|
RIKEN cDNA E130311K13 gene |
chr4_+_19575139 | 1.07 |
ENSMUST00000108253.1
ENSMUST00000029888.3 |
Rmdn1
|
regulator of microtubule dynamics 1 |
chr4_+_117252010 | 1.07 |
ENSMUST00000125943.1
ENSMUST00000106434.1 |
Tmem53
|
transmembrane protein 53 |
chr16_-_10543028 | 1.06 |
ENSMUST00000184863.1
ENSMUST00000038281.5 |
Dexi
|
dexamethasone-induced transcript |
chr5_+_90460889 | 1.06 |
ENSMUST00000031314.8
|
Alb
|
albumin |
chr15_-_76307231 | 1.06 |
ENSMUST00000023222.6
ENSMUST00000164189.1 |
Oplah
|
5-oxoprolinase (ATP-hydrolysing) |
chr11_+_101552135 | 1.05 |
ENSMUST00000103099.1
|
Nbr1
|
neighbor of Brca1 gene 1 |
chr4_+_117251951 | 1.05 |
ENSMUST00000062824.5
|
Tmem53
|
transmembrane protein 53 |
chr4_-_49549523 | 1.05 |
ENSMUST00000029987.9
|
Aldob
|
aldolase B, fructose-bisphosphate |
chr2_-_28563362 | 1.03 |
ENSMUST00000028161.5
|
Cel
|
carboxyl ester lipase |
chr14_+_73138755 | 1.02 |
ENSMUST00000171070.1
|
Rcbtb2
|
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2 |
chr3_-_73708399 | 1.02 |
ENSMUST00000029367.5
|
Bche
|
butyrylcholinesterase |
chr4_+_57845240 | 1.01 |
ENSMUST00000102903.1
ENSMUST00000107598.3 |
Akap2
|
A kinase (PRKA) anchor protein 2 |
chr15_+_31568851 | 1.00 |
ENSMUST00000070918.6
|
Cmbl
|
carboxymethylenebutenolidase-like (Pseudomonas) |
chr6_+_115675983 | 1.00 |
ENSMUST00000068960.9
|
D830050J10Rik
|
RIKEN cDNA D830050J10 gene |
chr3_+_19957088 | 0.99 |
ENSMUST00000108328.1
|
Cp
|
ceruloplasmin |
chr12_-_84876479 | 0.98 |
ENSMUST00000163189.1
ENSMUST00000110254.2 ENSMUST00000002073.6 |
Ltbp2
|
latent transforming growth factor beta binding protein 2 |
chr10_-_89533550 | 0.98 |
ENSMUST00000105297.1
|
Nr1h4
|
nuclear receptor subfamily 1, group H, member 4 |
chr19_+_4081565 | 0.98 |
ENSMUST00000159593.1
|
Cabp2
|
calcium binding protein 2 |
chr11_-_75796048 | 0.97 |
ENSMUST00000021209.7
|
Doc2b
|
double C2, beta |
chr1_-_72284248 | 0.97 |
ENSMUST00000097698.4
ENSMUST00000027381.6 |
Pecr
|
peroxisomal trans-2-enoyl-CoA reductase |
chr7_-_31055594 | 0.96 |
ENSMUST00000039909.6
|
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
chr9_-_104102550 | 0.96 |
ENSMUST00000050139.4
|
Ackr4
|
atypical chemokine receptor 4 |
chr3_-_10335650 | 0.94 |
ENSMUST00000078748.3
|
Slc10a5
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 5 |
chr11_+_69326252 | 0.93 |
ENSMUST00000018614.2
|
Kcnab3
|
potassium voltage-gated channel, shaker-related subfamily, beta member 3 |
chr4_+_95967205 | 0.93 |
ENSMUST00000030306.7
|
Hook1
|
hook homolog 1 (Drosophila) |
chr5_+_145345254 | 0.93 |
ENSMUST00000079268.7
|
Cyp3a57
|
cytochrome P450, family 3, subfamily a, polypeptide 57 |
chr3_-_121815212 | 0.92 |
ENSMUST00000029770.5
|
Abcd3
|
ATP-binding cassette, sub-family D (ALD), member 3 |
chr3_+_19957037 | 0.90 |
ENSMUST00000091309.5
ENSMUST00000108329.1 ENSMUST00000003714.6 |
Cp
|
ceruloplasmin |
chr4_+_99030946 | 0.90 |
ENSMUST00000030280.6
|
Angptl3
|
angiopoietin-like 3 |
chrX_-_49288195 | 0.89 |
ENSMUST00000114914.1
|
Enox2
|
ecto-NOX disulfide-thiol exchanger 2 |
chr3_-_86002491 | 0.89 |
ENSMUST00000061343.3
|
Prss48
|
protease, serine, 48 |
chr11_+_49280150 | 0.89 |
ENSMUST00000078932.1
|
Olfr1393
|
olfactory receptor 1393 |
chr13_-_92354943 | 0.89 |
ENSMUST00000022220.6
|
Msh3
|
mutS homolog 3 (E. coli) |
chr8_-_3694167 | 0.89 |
ENSMUST00000005678.4
|
Fcer2a
|
Fc receptor, IgE, low affinity II, alpha polypeptide |
chr7_+_140920896 | 0.86 |
ENSMUST00000183845.1
ENSMUST00000106045.1 |
Nlrp6
|
NLR family, pyrin domain containing 6 |
chr14_+_53390570 | 0.85 |
ENSMUST00000103636.2
|
Trav7-2
|
T cell receptor alpha variable 7-2 |
chr7_+_140920940 | 0.85 |
ENSMUST00000184560.1
|
Nlrp6
|
NLR family, pyrin domain containing 6 |
chr4_-_128618609 | 0.85 |
ENSMUST00000074829.2
|
Tlr12
|
toll-like receptor 12 |
chr13_+_92354783 | 0.85 |
ENSMUST00000022218.4
|
Dhfr
|
dihydrofolate reductase |
chr17_-_36058371 | 0.84 |
ENSMUST00000113742.2
|
Gm11127
|
predicted gene 11127 |
chr5_-_115484297 | 0.83 |
ENSMUST00000112067.1
|
Sirt4
|
sirtuin 4 |
chr3_+_19957240 | 0.82 |
ENSMUST00000108325.2
|
Cp
|
ceruloplasmin |
chr7_-_45103747 | 0.82 |
ENSMUST00000003512.7
|
Fcgrt
|
Fc receptor, IgG, alpha chain transporter |
chr2_+_14229390 | 0.82 |
ENSMUST00000028045.2
|
Mrc1
|
mannose receptor, C type 1 |
chr5_-_38491948 | 0.82 |
ENSMUST00000129099.1
|
Slc2a9
|
solute carrier family 2 (facilitated glucose transporter), member 9 |
chr9_-_9239052 | 0.82 |
ENSMUST00000093893.5
|
Arhgap42
|
Rho GTPase activating protein 42 |
chr11_-_96916448 | 0.81 |
ENSMUST00000103152.4
|
Cdk5rap3
|
CDK5 regulatory subunit associated protein 3 |
chr14_+_51884982 | 0.81 |
ENSMUST00000167984.1
|
Mettl17
|
methyltransferase like 17 |
chr1_+_164115264 | 0.81 |
ENSMUST00000162746.1
|
Selp
|
selectin, platelet |
chr9_+_108290433 | 0.81 |
ENSMUST00000035227.6
|
Nicn1
|
nicolin 1 |
chr9_+_119402444 | 0.80 |
ENSMUST00000035093.8
ENSMUST00000165044.1 |
Acvr2b
|
activin receptor IIB |
chr9_-_103222063 | 0.80 |
ENSMUST00000170904.1
|
Trf
|
transferrin |
chr2_-_164473714 | 0.79 |
ENSMUST00000017864.2
|
Trp53tg5
|
transformation related protein 53 target 5 |
chrX_-_49288229 | 0.79 |
ENSMUST00000114918.2
ENSMUST00000033437.8 ENSMUST00000114912.1 ENSMUST00000114911.1 |
Enox2
|
ecto-NOX disulfide-thiol exchanger 2 |
chr6_-_136875794 | 0.78 |
ENSMUST00000032342.1
|
Mgp
|
matrix Gla protein |
chr8_-_71395794 | 0.77 |
ENSMUST00000049184.7
|
Ushbp1
|
Usher syndrome 1C binding protein 1 |
chr14_-_75787031 | 0.77 |
ENSMUST00000022580.6
|
Slc25a30
|
solute carrier family 25, member 30 |
chr9_+_124121534 | 0.77 |
ENSMUST00000111442.1
ENSMUST00000171499.2 |
Ccr5
|
chemokine (C-C motif) receptor 5 |
chr3_+_145758674 | 0.76 |
ENSMUST00000029845.8
|
Ddah1
|
dimethylarginine dimethylaminohydrolase 1 |
chr7_-_119459266 | 0.76 |
ENSMUST00000033255.5
|
Gp2
|
glycoprotein 2 (zymogen granule membrane) |
chr4_+_134065897 | 0.74 |
ENSMUST00000137053.1
|
Aim1l
|
absent in melanoma 1-like |
chr7_+_19212521 | 0.73 |
ENSMUST00000060225.4
|
Gpr4
|
G protein-coupled receptor 4 |
chr1_-_153851189 | 0.73 |
ENSMUST00000059607.6
|
5830403L16Rik
|
RIKEN cDNA 5830403L16 gene |
chr2_+_122147680 | 0.73 |
ENSMUST00000102476.4
|
B2m
|
beta-2 microglobulin |
chr6_+_41538218 | 0.73 |
ENSMUST00000103291.1
|
Trbc1
|
T cell receptor beta, constant region 1 |
chr11_-_50887443 | 0.73 |
ENSMUST00000050595.6
ENSMUST00000163301.1 ENSMUST00000109131.1 ENSMUST00000125749.1 |
Zfp454
|
zinc finger protein 454 |
chr13_+_34734837 | 0.73 |
ENSMUST00000039605.6
|
Fam50b
|
family with sequence similarity 50, member B |
chr13_+_63282142 | 0.72 |
ENSMUST00000159152.1
|
2010111I01Rik
|
RIKEN cDNA 2010111I01 gene |
chrX_-_75380041 | 0.72 |
ENSMUST00000114085.2
|
F8
|
coagulation factor VIII |
chr14_+_51884842 | 0.71 |
ENSMUST00000047899.6
ENSMUST00000164902.1 |
Mettl17
|
methyltransferase like 17 |
chrX_+_150588223 | 0.71 |
ENSMUST00000153221.1
|
Pfkfb1
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
chr14_+_53676141 | 0.71 |
ENSMUST00000103662.4
|
Trav9-4
|
T cell receptor alpha variable 9-4 |
chr7_-_103840427 | 0.71 |
ENSMUST00000106866.1
|
Hbb-bh2
|
hemoglobin beta, bh2 |
chr19_-_44029201 | 0.70 |
ENSMUST00000026211.8
|
Cyp2c44
|
cytochrome P450, family 2, subfamily c, polypeptide 44 |
chr6_-_43666158 | 0.70 |
ENSMUST00000114644.2
ENSMUST00000150599.1 ENSMUST00000067888.7 |
Tpk1
|
thiamine pyrophosphokinase |
chr2_-_66634653 | 0.69 |
ENSMUST00000164384.2
ENSMUST00000169900.1 |
Scn9a
|
sodium channel, voltage-gated, type IX, alpha |
chr5_-_104021799 | 0.69 |
ENSMUST00000119025.1
|
Hsd17b11
|
hydroxysteroid (17-beta) dehydrogenase 11 |
chr8_+_70718534 | 0.69 |
ENSMUST00000179347.1
|
Gm3336
|
predicted gene 3336 |
chr3_+_135825788 | 0.69 |
ENSMUST00000167390.1
|
Slc39a8
|
solute carrier family 39 (metal ion transporter), member 8 |
chr7_-_126585775 | 0.68 |
ENSMUST00000084589.4
|
Cln3
|
ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
chr7_+_44849949 | 0.68 |
ENSMUST00000141311.1
ENSMUST00000107880.1 |
Akt1s1
|
AKT1 substrate 1 (proline-rich) |
chr14_+_55094835 | 0.68 |
ENSMUST00000050575.7
|
Thtpa
|
thiamine triphosphatase |
chr9_+_45055166 | 0.68 |
ENSMUST00000114664.1
ENSMUST00000093856.3 |
Mpzl3
|
myelin protein zero-like 3 |
chr14_-_68582078 | 0.68 |
ENSMUST00000022641.7
|
Adamdec1
|
ADAM-like, decysin 1 |
chr16_-_56717182 | 0.67 |
ENSMUST00000141404.1
|
Tfg
|
Trk-fused gene |
chr1_+_165461037 | 0.67 |
ENSMUST00000027853.5
|
Mpc2
|
mitochondrial pyruvate carrier 2 |
chr11_+_99873389 | 0.67 |
ENSMUST00000093936.3
|
Krtap9-1
|
keratin associated protein 9-1 |
chr7_-_45615484 | 0.67 |
ENSMUST00000033099.4
|
Fgf21
|
fibroblast growth factor 21 |
chr6_+_72598475 | 0.66 |
ENSMUST00000070597.6
ENSMUST00000176364.1 ENSMUST00000176168.1 |
Retsat
|
retinol saturase (all trans retinol 13,14 reductase) |
chr10_-_75797528 | 0.66 |
ENSMUST00000120177.1
|
Gstt1
|
glutathione S-transferase, theta 1 |
chr18_+_37484955 | 0.66 |
ENSMUST00000053856.4
|
Pcdhb17
|
protocadherin beta 17 |
chrX_-_160994665 | 0.65 |
ENSMUST00000087104.4
|
Cdkl5
|
cyclin-dependent kinase-like 5 |
chr11_+_108395288 | 0.65 |
ENSMUST00000000049.5
|
Apoh
|
apolipoprotein H |
chr18_-_34720269 | 0.65 |
ENSMUST00000025224.7
|
Gfra3
|
glial cell line derived neurotrophic factor family receptor alpha 3 |
chr4_+_126609818 | 0.65 |
ENSMUST00000097886.3
ENSMUST00000164362.1 |
5730409E04Rik
|
RIKEN cDNA 5730409E04Rik gene |
chrX_-_95478107 | 0.64 |
ENSMUST00000033549.2
|
Asb12
|
ankyrin repeat and SOCS box-containing 12 |
chr6_+_114282635 | 0.64 |
ENSMUST00000032454.5
|
Slc6a1
|
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
chr16_+_35022394 | 0.64 |
ENSMUST00000061156.8
|
Ptplb
|
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b |
chr4_+_108165432 | 0.64 |
ENSMUST00000052999.6
|
Echdc2
|
enoyl Coenzyme A hydratase domain containing 2 |
chr4_+_108165449 | 0.64 |
ENSMUST00000116309.3
ENSMUST00000116307.1 |
Echdc2
|
enoyl Coenzyme A hydratase domain containing 2 |
chrX_+_73151134 | 0.64 |
ENSMUST00000097221.3
|
Xlr5b
|
X-linked lymphocyte-regulated 5B |
chrX_+_93183227 | 0.64 |
ENSMUST00000088133.3
|
BC061195
|
cDNA sequence BC061195 |
chr3_-_104366613 | 0.63 |
ENSMUST00000056145.2
|
Gm5546
|
predicted gene 5546 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.1 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
1.5 | 5.9 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.2 | 3.5 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) |
1.1 | 3.4 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
1.1 | 12.0 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.9 | 2.7 | GO:1901377 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) |
0.9 | 1.8 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.8 | 2.4 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.7 | 2.2 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.7 | 9.8 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.6 | 8.8 | GO:0015747 | urate transport(GO:0015747) |
0.5 | 1.6 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
0.5 | 5.5 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
0.5 | 2.4 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.5 | 1.9 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.5 | 1.4 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.4 | 1.8 | GO:1901373 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
0.4 | 5.6 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.4 | 2.5 | GO:1904073 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.4 | 2.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.3 | 2.8 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.3 | 0.3 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) |
0.3 | 0.9 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.3 | 1.2 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.3 | 1.0 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.2 | 1.2 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.2 | 1.7 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.2 | 0.2 | GO:0018307 | enzyme active site formation(GO:0018307) |
0.2 | 1.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.7 | GO:0018900 | dichloromethane metabolic process(GO:0018900) |
0.2 | 6.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.2 | 0.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 0.6 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.2 | 0.6 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.2 | 1.4 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.2 | 1.1 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.2 | 4.5 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.2 | 0.9 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 0.2 | GO:1990773 | regulation of matrix metallopeptidase secretion(GO:1904464) matrix metallopeptidase secretion(GO:1990773) |
0.2 | 0.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 0.5 | GO:0090265 | immune complex clearance by monocytes and macrophages(GO:0002436) monocyte homeostasis(GO:0035702) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) |
0.2 | 1.0 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.2 | 0.8 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
0.2 | 0.8 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.6 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.9 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.1 | 0.7 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.1 | 0.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.8 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.1 | 0.7 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.1 | 0.4 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 1.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.5 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.1 | 0.9 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.1 | 4.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 1.7 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 2.0 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.3 | GO:1902569 | regulation of activation of JAK2 kinase activity(GO:0010534) activation of JAK2 kinase activity(GO:0042977) negative regulation of activation of JAK2 kinase activity(GO:1902569) |
0.1 | 2.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.3 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.1 | 1.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.5 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 0.3 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.1 | 0.6 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 0.6 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.1 | 0.3 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 1.2 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.4 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.1 | 1.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 0.3 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.4 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 0.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.4 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 0.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.6 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.8 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.3 | GO:0071338 | positive regulation of hair follicle cell proliferation(GO:0071338) |
0.1 | 0.3 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.1 | 1.0 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.3 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.1 | 0.3 | GO:0038001 | paracrine signaling(GO:0038001) tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 1.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.8 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 1.2 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 0.4 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.7 | GO:0033133 | fructose 2,6-bisphosphate metabolic process(GO:0006003) positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.4 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 0.6 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.1 | 0.7 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.8 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 4.8 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
0.1 | 1.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 2.1 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.1 | 0.4 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 1.5 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.3 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 | 1.0 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 1.0 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.5 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.1 | 1.8 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.8 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.6 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 0.2 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
0.1 | 1.3 | GO:0099563 | modification of synaptic structure(GO:0099563) |
0.1 | 0.2 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.2 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.1 | 0.2 | GO:0051030 | snRNA transport(GO:0051030) |
0.1 | 0.3 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.1 | GO:2000157 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.1 | 0.6 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.4 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.1 | 0.1 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.1 | 0.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.1 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.1 | 0.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.9 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.6 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.1 | 0.2 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.1 | 0.2 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.0 | 0.5 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.0 | 0.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.3 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 0.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.0 | 0.2 | GO:0032468 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.0 | 0.1 | GO:0070649 | meiotic chromosome movement towards spindle pole(GO:0016344) formin-nucleated actin cable assembly(GO:0070649) |
0.0 | 0.2 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 | 0.3 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.2 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) regulation of vesicle size(GO:0097494) |
0.0 | 0.5 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.6 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 1.4 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.6 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.1 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
0.0 | 0.5 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.5 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.3 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.0 | 0.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 4.0 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.0 | 0.4 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 2.5 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.0 | 0.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.2 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.4 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.0 | 0.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.1 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.0 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.0 | 0.6 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.8 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.2 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.0 | 0.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 1.7 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 2.0 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.4 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 1.1 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.0 | 1.5 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.4 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.2 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.2 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.0 | 2.6 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.0 | 0.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 1.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.2 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.1 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) negative regulation of ATP biosynthetic process(GO:2001170) |
0.0 | 0.2 | GO:1904259 | positive regulation of extracellular matrix assembly(GO:1901203) regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.0 | 1.1 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.0 | 0.2 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.0 | 2.2 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 2.6 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
0.0 | 1.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.3 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) cardiac muscle fiber development(GO:0048739) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.2 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.3 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.0 | 0.1 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
0.0 | 0.4 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 1.5 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.0 | 0.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.2 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
0.0 | 0.7 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.5 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.0 | 1.0 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.6 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.0 | 1.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.1 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.0 | 0.3 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.0 | 0.1 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.0 | 0.3 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 2.3 | GO:0007416 | synapse assembly(GO:0007416) |
0.0 | 2.0 | GO:0030178 | negative regulation of Wnt signaling pathway(GO:0030178) |
0.0 | 0.3 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.6 | GO:0006505 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.6 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.0 | 0.5 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.7 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.0 | 0.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.0 | 0.1 | GO:0042435 | serotonin biosynthetic process(GO:0042427) indole-containing compound biosynthetic process(GO:0042435) primary amino compound biosynthetic process(GO:1901162) |
0.0 | 0.1 | GO:0009301 | snRNA transcription(GO:0009301) |
0.0 | 0.2 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.2 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 2.3 | GO:0046879 | hormone secretion(GO:0046879) |
0.0 | 0.3 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.5 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.0 | 0.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 1.1 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 4.5 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.3 | 2.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 2.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.2 | 0.7 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.2 | 1.0 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 0.6 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.2 | 0.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 2.8 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.6 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 3.9 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 1.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.9 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.5 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.5 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 0.6 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 0.9 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 2.1 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.6 | GO:0031673 | H zone(GO:0031673) |
0.1 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.3 | GO:0098830 | presynaptic endosome(GO:0098830) presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
0.1 | 0.9 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.6 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.8 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 2.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.4 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 5.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.3 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 7.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 2.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 1.1 | GO:0061702 | inflammasome complex(GO:0061702) |
0.1 | 0.2 | GO:1990032 | parallel fiber(GO:1990032) |
0.0 | 0.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.5 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.0 | 0.4 | GO:0097227 | sperm annulus(GO:0097227) |
0.0 | 0.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 0.6 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.2 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.0 | 0.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.1 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.0 | 0.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 1.9 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.9 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.7 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 1.4 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.8 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 2.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.3 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.8 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.5 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.3 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 39.5 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 1.2 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 1.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 1.0 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 2.3 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.3 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 1.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 1.5 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 5.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 1.5 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 1.0 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 0.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.1 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
0.0 | 0.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.1 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
3.0 | 12.0 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
1.6 | 4.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.5 | 4.5 | GO:0019002 | GMP binding(GO:0019002) |
1.3 | 3.8 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
0.9 | 4.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.7 | 2.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.7 | 2.8 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.6 | 9.6 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.6 | 2.2 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
0.5 | 8.0 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.5 | 2.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.5 | 2.4 | GO:0016726 | aldehyde oxidase activity(GO:0004031) xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.4 | 1.8 | GO:0033814 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
0.4 | 1.2 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.4 | 15.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.4 | 1.2 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.4 | 1.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.4 | 1.1 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
0.3 | 1.0 | GO:0004771 | sterol esterase activity(GO:0004771) retinyl-palmitate esterase activity(GO:0050253) |
0.3 | 3.7 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.3 | 1.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 1.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 1.5 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.3 | 1.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.3 | 2.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 0.9 | GO:0032142 | dinucleotide insertion or deletion binding(GO:0032139) single guanine insertion binding(GO:0032142) |
0.3 | 4.3 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.3 | 1.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.3 | 7.0 | GO:0070330 | aromatase activity(GO:0070330) |
0.2 | 0.9 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.2 | 1.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 1.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.2 | 0.7 | GO:0016824 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.2 | 0.8 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 4.8 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 2.0 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 1.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 2.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 1.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 0.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 4.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 1.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 2.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 6.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.2 | 0.9 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 0.5 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.2 | 0.5 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.2 | 0.8 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.2 | 1.4 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.2 | 0.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 1.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.4 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 1.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 1.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 3.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 1.8 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.4 | GO:0047936 | glucose 1-dehydrogenase [NAD(P)] activity(GO:0047936) |
0.1 | 1.7 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.9 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 1.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.3 | GO:0070540 | stearic acid binding(GO:0070540) |
0.1 | 0.3 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.1 | 0.5 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.6 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 0.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.3 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.5 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.6 | GO:0005223 | intracellular cAMP activated cation channel activity(GO:0005222) intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 2.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.7 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.4 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.1 | 0.3 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.1 | 2.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.4 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.6 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 2.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.8 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.3 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.1 | 1.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 1.7 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 1.7 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.5 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 2.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.2 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.1 | 0.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.1 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.8 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 1.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.4 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.4 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.2 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) |
0.0 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.3 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 2.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.2 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
0.0 | 0.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.6 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.0 | 0.1 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.0 | 0.7 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 0.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.1 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.0 | 0.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.8 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.3 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 1.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.8 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.1 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.0 | 0.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 1.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.4 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.7 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 3.4 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.9 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.1 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.5 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.4 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 0.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 1.0 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 1.0 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.9 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 1.5 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.0 | 0.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 2.0 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 0.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 1.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 3.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 3.9 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 1.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 1.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 2.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 2.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 1.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.6 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 3.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 7.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.5 | 6.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.3 | 0.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 4.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 2.8 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 0.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 2.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 2.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 2.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 1.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 3.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 7.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.6 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.0 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 2.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 1.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 1.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 1.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.9 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 1.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.7 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 2.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 1.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.1 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 0.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |